Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fresenius Medical Care AG (FMS) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to 9.75%.

  • Fresenius Medical Care AG's EBITDA Margin fell 76400.0% to 9.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.89%, marking a year-over-year decrease of 30200.0%. This contributed to the annual value of 17.47% for FY2024, which is 400.0% up from last year.
  • As of Q3 2025, Fresenius Medical Care AG's EBITDA Margin stood at 9.75%, which was down 76400.0% from 16.72% recorded in Q2 2025.
  • Fresenius Medical Care AG's EBITDA Margin's 5-year high stood at 20.47% during Q1 2021, with a 5-year trough of 4.37% in Q4 2022.
  • In the last 5 years, Fresenius Medical Care AG's EBITDA Margin had a median value of 16.39% in 2023 and averaged 15.35%.
  • As far as peak fluctuations go, Fresenius Medical Care AG's EBITDA Margin soared by 127500bps in 2023, and later crashed by -76400bps in 2025.
  • Fresenius Medical Care AG's EBITDA Margin (Quarter) stood at 5.03% in 2021, then fell by -13bps to 4.37% in 2022, then surged by 292bps to 17.12% in 2023, then fell by -15bps to 14.47% in 2024, then tumbled by -33bps to 9.75% in 2025.
  • Its EBITDA Margin was 9.75% in Q3 2025, compared to 16.72% in Q2 2025 and 14.87% in Q1 2025.